Your browser doesn't support javascript.
loading
DNA barcoded competitive clone-initiating cell analysis reveals novel features of metastatic growth in a cancer xenograft model.
Aalam, Syed Mohammed Musheer; Tang, Xiaojia; Song, Jianning; Ray, Upasana; Russell, Stephen J; Weroha, S John; Bakkum-Gamez, Jamie; Shridhar, Viji; Sherman, Mark E; Eaves, Connie J; Knapp, David J H F; Kalari, Krishna R; Kannan, Nagarajan.
Afiliação
  • Aalam SMM; Division of Experimental Pathology and Laboratory Medicine, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Tang X; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
  • Song J; Division of Experimental Pathology and Laboratory Medicine, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Ray U; Division of Experimental Pathology and Laboratory Medicine, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Russell SJ; Department of Molecular Medicine, Mayo Clinic, MN 55905, USA.
  • Weroha SJ; Department of Oncology, Mayo Clinic, Rochester, MN, USA.
  • Bakkum-Gamez J; Division of Gynecologic Oncology Surgery, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, USA.
  • Shridhar V; Division of Experimental Pathology and Laboratory Medicine, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Sherman ME; Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, FL, USA.
  • Eaves CJ; Terry Fox Laboratory, British Columbia Cancer Research Institute, Vancouver, BC, Canada.
  • Knapp DJHF; Division of Experimental Pathology and Laboratory Medicine, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Kalari KR; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
  • Kannan N; Division of Experimental Pathology and Laboratory Medicine, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
NAR Cancer ; 4(3): zcac022, 2022 Sep.
Article em En | MEDLINE | ID: mdl-35875052
ABSTRACT
A problematic feature of many human cancers is a lack of understanding of mechanisms controlling organ-specific patterns of metastasis, despite recent progress in identifying many mutations and transcriptional programs shown to confer this potential. To address this gap, we developed a methodology that enables different aspects of the metastatic process to be comprehensively characterized at a clonal resolution. Our approach exploits the application of a computational pipeline to analyze and visualize clonal data obtained from transplant experiments in which a cellular DNA barcoding strategy is used to distinguish the separate clonal contributions of two or more competing cell populations. To illustrate the power of this methodology, we demonstrate its ability to discriminate the metastatic behavior in immunodeficient mice of a well-established human metastatic cancer cell line and its co-transplanted LRRC15 knockdown derivative. We also show how the use of machine learning to quantify clone-initiating cell (CIC) numbers and their subsequent metastatic progeny generated in different sites can reveal previously unknown relationships between different cellular genotypes and their initial sites of implantation with their subsequent respective dissemination patterns. These findings underscore the potential of such combined genomic and computational methodologies to identify new clonally-relevant drivers of site-specific patterns of metastasis.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: NAR Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: NAR Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos